B · Normal
[Pfizer Pharmaceuticals raises full-year adjusted earnings per share forecast] November 3rd, Pfizer Pharmaceuticals expects adjusted earnings per share for the full year to be US$2.95 to US$3.05, compared with the previous forecast of US$2.80 to US$3.00, and the market estimate of US$2.96.
U.S. stock trends 🕐 2026-11-03 19:46
#Pfizer #U.S. stock trends #medicine #Pharmaceutical business
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

On November 3, investment bank D.A. Davidson raised Apple’s price tag from $270 11-03 20:19 [Susquehanna lowers the target price of Lumentum and Marvel] On November 3, Susq 11-03 20:18 On November 3rd, Susquehanna lowered the target price of Lumentum from US$1,100 11-03 20:18 On November 3rd, Shopify’s US stocks fell 17% before the market opened; the comp 11-03 20:03 On November 3rd, Bernstein lowered the target price of Lumentum (LITE.O) from US 11-03 19:58 [Pfizer Eliquis sales increased by 25% in the third quarter and Padcev increased 11-03 19:52

Comments

0/500
Captcha (click to refresh)
No comments yet